Results 161 to 170 of about 757,873 (207)

Granulomas in the Heart: Pathophysiology, Diagnosis, Management, and Outcomes in Cardiac Sarcoidosis. [PDF]

Cureus
Alnasralla MB, Subbaraman B.
europepmc   +1 more source

Heart in the crossfire, from epsilon to beyond: cardiac sarcoidosis-a case report. [PDF]

Eur Heart J Case Rep
Ali H, Che Hassan HH, Mohamad MSF, Beh BC.   +3 more
europepmc   +1 more source

Resuscitated Cardiac Arrest From Cardiac Sarcoidosis in a Professional Basketball Player: A Slam Dunk Diagnosis? [PDF]

JACC Case Rep
Pillai B, Hardin EA, Link MS, Kato K, Levine BD.   +4 more
europepmc   +1 more source

Prognostic impact of corticosteroid maintenance dose and re-escalation in patients with cardiac sarcoidosis. [PDF]

Open Heart
Nishimura T, Ishibashi K, Kanaoka K, Nakajima K, Ikee T, Syako D, Nakamura T, Oka S, Wakamiya A, Ueda N, Kamakura T, Wada M, Inoue Y, Miyamoto K, Aiba T, Kusano K.   +15 more
europepmc   +1 more source

Strict carbohydrate restriction enables volume-based FDG-PET/CT to outperform SUVmax for risk stratification in cardiac sarcoidosis. [PDF]

Int J Cardiol Heart Vasc
Fukushima Y, Ando T, Yodogawa K, Igarashi T, Hayashi H, Kumita S.   +5 more
europepmc   +1 more source

Association of cardiac sarcoidosis with coronary slow flow: a case report unraveling the enigma. [PDF]

Eur Heart J Case Rep
Hussein H, Radhakrishnan A, Gul U, Dhanjal T.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cardiac sarcoidosis

Internal Medicine Journal, 2008
AbstractCardiac sarcoidosis can have a variety of manifestations including conduction disease, congestive heart failure, valvular heart disease, pericardial effusions, tamponade, ventricular arrhythmias and sudden cardiac death. In patients with sarcoidosis, the reported incidence of cardiac involvement ranges from 20% in US autopsy studies to nearly ...
J, Habersberger, V, Manins, A J, Taylor
  +7 more sources

Cardiac Sarcoidosis

Seminars in Respiratory and Critical Care Medicine, 2020
AbstractApproximately 5% of patients with sarcoidosis will have clinically manifest cardiac involvement presenting with one or more of ventricular arrhythmias, conduction abnormalities, and heart failure. It is estimated that another 20 to 25% of pulmonary/systemic sarcoidosis patients have asymptomatic cardiac involvement (clinically silent disease ...
null Rahul B. Jadhav, MD, null Khushboo Gupta, MD   +1 more
openaire   +3 more sources